A study has identified a number of potential biomarkers that clinicians can use to predict how their patients will respond to treatment.

Imjudo plus Imfinzi improved overall survival compared with standard targeted therapy for hepatocellular carcinoma.

People with hepatocellular carcinoma had improved survival after the advent of direct-acting antiviral therapy.

However, people with liver cirrhosis remain at risk and should continue screening even after being cured.

People under 50 are increasingly likely to develop cancers of the breast, colon, liver and more.

New study supports U.S. guidelines for determining which people with liver cancer are eligible for a transplant.

Second- and third-generation individuals in Los Angeles had a 35% and 61% higher risk, respectively, than those born in Mexico.

“I’m glad to go to bat for the One Liver to Love initiative to encourage others to be proactive,” says Latino legend Bernie Williams.

The risk of HCC fell further as cumulative antihistamine use rose in people with HBV, HCV or both.

A new report stresses the need for better access to health insurance coverage to improve cancer care and outcomes.